力生制药：股票交易异常波动

Core Viewpoint - The company, Lisheng Pharmaceutical (002393), has experienced a significant stock price increase, with a cumulative rise of over 20% in the last two trading days, indicating abnormal trading activity [1] Company Information - The company has confirmed that there is no need to correct or supplement previously disclosed information, and no undisclosed significant information that could affect stock trading prices has been found recently [1] - The company's recent operational status is normal, and there have been no significant changes in the internal or external environment [1] - The company, its controlling shareholder, and actual controller do not have any undisclosed significant matters or major matters under planning [1] - There are no instances of the controlling shareholder or actual controller trading the company's stock [1]